{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:40:55Z","timestamp":1793353255982,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1053\/j.ajkd.2019.10.004","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T08:26:24Z","timestamp":1580804784000},"page":"830-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1053","volume":"75","author":[{"given":"K\u00e4the","family":"Goossen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"B\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Breuing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Firanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Nariai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Sloand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ik","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinBor","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9981","key":"10.1053\/j.ajkd.2019.10.004_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2019.10.004_bib2","first-page":"S461","article-title":"US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States: Chapter 11: International Comparisons","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib3","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00321.x","article-title":"Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial","volume":"64","author":"Korevaar","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MNH.0000000000000114","article-title":"Dialysis modality and survival: does the controversy live on?","volume":"24","author":"Merchant","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN108382","article-title":"Peritoneal dialysis: update on patient survival","volume":"83","author":"Teixeira","year":"2015","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/sdi.12692","article-title":"Dialysis modality and survival: done to death","volume":"31","author":"Trinh","year":"2018","journal-title":"Semin Dial"},{"issue":"13-14","key":"10.1053\/j.ajkd.2019.10.004_bib7","first-page":"210","article-title":"Satisfaction of patients on chronic haemodialysis and peritoneal dialysis","volume":"136","author":"Wasserfallen","year":"2006","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jama.291.6.697","article-title":"Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis","volume":"291","author":"Rubin","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2215\/CJN.01220406","article-title":"Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives","volume":"1","author":"Juergensen","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.ajkd.2012.08.045","article-title":"The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies","volume":"61","author":"Tong","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2215\/CJN.03980510","article-title":"Depressed mood, usual activity level, and continued employment after starting dialysis","volume":"5","author":"Kutner","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2215\/CJN.02550310","article-title":"Factors affecting employment at initiation of dialysis","volume":"6","author":"Muehrer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib13","first-page":"439","article-title":"Employment in the patient with chronic kidney disease related to renal replacement therapy","volume":"32","author":"Julian Mauro","year":"2012","journal-title":"Nefrologia"},{"issue":"5","key":"10.1053\/j.ajkd.2019.10.004_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.ajkd.2011.08.025","article-title":"Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland","volume":"59","author":"Helantera","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2019.10.004_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/nep.12482","article-title":"Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-centre survey of Japanese patients","volume":"20","author":"Nakayama","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1093\/ndt\/gfq212","article-title":"Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients","volume":"25","author":"Brown","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000484115","article-title":"Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis","volume":"42","author":"Zazzeroni","year":"2017","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib18","first-page":"190","article-title":"The impact of dialysis modality on quality of life: a systematic review","volume":"37","author":"Boateng","year":"2011","journal-title":"J\u00a0Renal Care"},{"issue":"9","key":"10.1053\/j.ajkd.2019.10.004_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001307","article-title":"A\u00a0systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","author":"Wyld","year":"2012","journal-title":"PLoS Med"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1185\/030079908X253410","article-title":"Utility of health states in chronic kidney disease: a structured review of the literature","volume":"24","author":"Dale","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1524-4733.2007.00308.x","article-title":"Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis","volume":"11","author":"Liem","year":"2008","journal-title":"Value Health"},{"issue":"8","key":"10.1053\/j.ajkd.2019.10.004_bib22","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/ndt\/gfq085","article-title":"Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization","volume":"25","author":"Oliver","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ndt\/gfn484","article-title":"A\u00a0prospective evaluation of renal replacement therapy modality eligibility","volume":"24","author":"Mendelssohn","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3747\/pdi.2015.00218","article-title":"Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure","volume":"36","author":"Lan","year":"2016","journal-title":"Perit Dial Int"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1046\/j.1523-1755.1999.00353.x","article-title":"Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group","volume":"55","author":"Jager","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3747\/pdi.2008.00277","article-title":"Time-dependent reasons for peritoneal dialysis technique failure and mortality","volume":"30","author":"Kolesnyk","year":"2010","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib27","first-page":"218","article-title":"Systemic and local impact of glucose and glucose degradation products in peritoneal dialysis solution","volume":"23","author":"Kim","year":"2013","journal-title":"J\u00a0Ren Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ki.1981.53","article-title":"Glucose absorption during continuous ambulatory peritoneal dialysis","volume":"19","author":"Grodstein","year":"1981","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.0894-0959.2004.17610.x","article-title":"Metabolic consequences of peritoneal dialysis","volume":"17","author":"Burkart","year":"2004","journal-title":"Semin Dial"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib30","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib31","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","article-title":"What really happens to people on long-term peritoneal dialysis?","volume":"54","author":"Davies","year":"1998","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2019.10.004_bib32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1251046","article-title":"Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis","volume":"12","author":"Davies","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2019.10.004_bib34","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1681\/ASN.2006030194","article-title":"Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis","volume":"17","author":"Brimble","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/089686089701700402","article-title":"What is the problem with high transporters?","volume":"17","author":"Blake","year":"1997","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/089686080302300106","article-title":"The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients","volume":"23","author":"Tonbul","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.ajkd.2019.10.004_bib37","first-page":"280","article-title":"Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?","volume":"28","author":"Bazzato","year":"1982","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08860228409080987","article-title":"Polycation as an alternative osmotic agent and phosphate binder in peritoneal dialysis","volume":"8","author":"McGary","year":"1984","journal-title":"Uremia Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000441-198501000-00002","article-title":"Evaluation of a peritoneal dialysis solution containing polymer","volume":"289","author":"Rubin","year":"1985","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ajkd.2019.10.004_bib40","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"10","author":"Htay","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1053\/j.ajkd.2019.10.004_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3109\/0886022X.2011.615965","article-title":"A\u00a0meta-analysis of icodextrin versus\u00a0glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients","volume":"33","author":"He","year":"2011","journal-title":"Ren Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3747\/pdi.2009.00264","article-title":"Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials","volume":"31","author":"Qi","year":"2011","journal-title":"Perit Dial Int"},{"issue":"10","key":"10.1053\/j.ajkd.2019.10.004_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001526","article-title":"Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data","volume":"10","author":"Wieseler","year":"2013","journal-title":"PLoS Med"},{"key":"10.1053\/j.ajkd.2019.10.004_bib44","doi-asserted-by":"crossref","unstructured":"Rohner E, Grabik M, Tonia T, et\u00a0al. Does access to clinical study\u00a0reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of\u00a0randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients. PLoS One. 2017;12(12):e0189309.","DOI":"10.1371\/journal.pone.0189309"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13063-016-1327-z","article-title":"Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials","volume":"17","author":"Hodkinson","year":"2016","journal-title":"Trials"},{"key":"10.1053\/j.ajkd.2019.10.004_bib47","doi-asserted-by":"crossref","first-page":"k294","DOI":"10.1136\/bmj.k294","article-title":"FDA to begin releasing clinical study reports in pilot programme","volume":"360","author":"Doshi","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmjebm-2018-110963","article-title":"When to include clinical study reports and regulatory documents in systematic reviews","volume":"23","author":"Jefferson","year":"2018","journal-title":"BMJ Evid Based Med"},{"issue":"7","key":"10.1053\/j.ajkd.2019.10.004_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1053\/j.ajkd.2019.10.004_bib50","article-title":"The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis","author":"Becker","year":"2018","journal-title":"PROSPERO"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib51","first-page":"35","article-title":"The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis","volume":"8","author":"Becker","year":"2019"},{"key":"10.1053\/j.ajkd.2019.10.004_bib54","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1046\/j.1523-1755.62.s81.10.x","article-title":"Early quality of life benefits of icodextrin in peritoneal dialysis","volume":"81","author":"Guo","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2019.10.004_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib59","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib65","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib66","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib67","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.10.004_bib69","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib74","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 7.7.3.2 Obtaining standard deviations from standard errors and confidence intervals for group means","author":"Higgins","year":"2011"},{"key":"10.1053\/j.ajkd.2019.10.004_bib75","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 16.1.3 Special topics in statistics: missing standard deviations","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib77","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 16.2 Special topics in statistics: intention-to-treat issues","author":"Higgins","year":"2011"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib78","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib79","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jrsm.1260","article-title":"Introduction, comparison, and validation of Meta-Essentials: a free and simple tool for meta-analysis","volume":"8","author":"Suurmond","year":"2017","journal-title":"Res Synthesis Methods"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/089686080102100308","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism","volume":"21","author":"Bredie","year":"2001","journal-title":"Perit Dial Int"},{"issue":"13","key":"10.1053\/j.ajkd.2019.10.004_bib82","doi-asserted-by":"crossref","first-page":"e2991","DOI":"10.1097\/MD.0000000000002991","article-title":"Effect of icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12882-018-0912-7","article-title":"Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: comparison between icodextrin solution and glucose-based solution","volume":"19","author":"Chen","year":"2018","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2019.10.004_bib84","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/gfu033","article-title":"Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis","volume":"29","author":"Chow","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2019.10.004_bib85","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib86","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","article-title":"Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)","volume":"30","author":"de Moraes","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib87","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2004090793","article-title":"Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration","volume":"16","author":"Finkelstein","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib88","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings","year":"2003","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib89","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.02950509","article-title":"Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid","volume":"4","author":"Lin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib90","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ki.1994.300","article-title":"A\u00a0randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis","volume":"46","author":"Mistry","year":"1994","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib91","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089686089501500309","article-title":"Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis","volume":"15","author":"Gokal","year":"1995","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib92","first-page":"211","article-title":"Clinical results of icodextrin dialysis solution in Japan: results of a double-blind comparative study using glucose dialysate as a control drug","volume":"55","author":"Ota","year":"2003","journal-title":"Kidney Dial"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib93","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Perit Dial Int"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib94","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib95","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/089686089701700613","article-title":"Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell","volume":"17","author":"Posthuma","year":"1997","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib96","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/12.3.550","article-title":"Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2019.10.004_bib97","first-page":"S106","article-title":"Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group","volume":"20","author":"Posthuma","year":"2000","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/089686080702700310","article-title":"Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study","volume":"27","author":"Rodriguez-Carmona","year":"2007","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib99","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.10.004_bib100","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/ajkd.2002.36344","article-title":"A\u00a0randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis","volume":"40","author":"Wolfson","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2019.10.004_bib101","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3346\/jkms.2014.29.9.1217","article-title":"Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients","volume":"29","author":"Yoon","year":"2014","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1053\/j.ajkd.2019.10.004_bib102","unstructured":"Yu CC, Yang CW, Wu CH, Weng SM, Huang CC. Icodextrin is effective to increase ultrafiltration volume in high and high-average transporter CAPD patients: a prospective study in comparison with dextrose dialysate. Poster and oral presentation at: Taiwan Society of Nephrology Annual Scientific Meeting; Kaohsiung, Taiwan; November 22-23, 2002."},{"key":"10.1053\/j.ajkd.2019.10.004_bib103","unstructured":"Baxter Healthcare Corp. A double-blind, randomised, controlled trial to assess the effects of Extraneal(TM) (icodextrin) compared to Dianeal\u00ae (7.5% PD4 (2.27% glucose) solution (both administered for the long dwell exchange) on fluid status, blood pressure and cardiovascular disease parameters in hypertensive peritoneal dialysis patients. Clinical Study Report PRO-RENAL-REG-40, November 17, 2002."},{"key":"10.1053\/j.ajkd.2019.10.004_bib104","unstructured":"Baxter Healthcare Corp. A study to evaluate the efficacy and safety of 7.5% icodextrin peritoneal dialysis solution as compared to Dianeal\u00ae PD-2 peritoneal dialysis solution with 4.25% dextrose, for the long dwell in patients treated with automated peritoneal dialysis (APD). Clinical Study Report RD-00-CA-050, January 27,\u00a02004."},{"key":"10.1053\/j.ajkd.2019.10.004_bib105","unstructured":"Baxter Healthcare Corp. A study to evaluate the safety and efficacy of 7.5% icodextrin peritoneal dialysis solution (Extraneal) compared to 2.5% dextrose Dianeal\u00ae PD-2 peritoneal dialysis solution in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Clinical Study Report CN-R-001, October 16, 2006."},{"key":"10.1053\/j.ajkd.2019.10.004_bib106","unstructured":"Baxter Healthcare Corp. Multicentre Clinical Trial oflcodextrin in CAPD Final Report Addendum (MIDAS). Clinical Study Report ML\/IB 001, October 4, 2000."},{"key":"10.1053\/j.ajkd.2019.10.004_bib107","unstructured":"Baxter Healthcare Corp. A clinical comparison study of BLPG in patients receiving continuous ambulatory peritoneal dialysis (CAPD). Clinical Study Report BLR-PG22, March 28, 2001."},{"key":"10.1053\/j.ajkd.2019.10.004_bib108","unstructured":"Baxter Healthcare Corp. A study to evaluate the safety and efficacy of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis (APD). Clinical Study Report PRO-RENAL-REG-035, August 26, 1998."},{"key":"10.1053\/j.ajkd.2019.10.004_bib109","unstructured":"Baxter Healthcare Corp. Assessment of the biocompatibility of glucose polymer solution in automated peritoneal dialysis (APD). Clinical Study Report ML\/IB 011 (DIANA), October 9, 2000."},{"key":"10.1053\/j.ajkd.2019.10.004_bib110","unstructured":"Baxter Healthcare Corp. 7.5% icodextrin peritoneal dialysis solution- a study to evaluate the safety and efficacy of a 7.5% icodextrin peritoneal dialysis solution in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Clinical Study Report RD-97-CA-130, September 28, 2000."},{"key":"10.1053\/j.ajkd.2019.10.004_bib111","unstructured":"Baxter Healthcare Corp. A study to evaluate the safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with peritoneal dialysis (PD) in North America. Clinical Study Report RD-97-CA-131, December 11, 2000."},{"key":"10.1053\/j.ajkd.2019.10.004_bib112","unstructured":"Baxter Healthcare Corp. A randomized, cross-over, comparative trial to evaluate the efficacy and safety of 7.5% icodextrin perioneal dialysis solution in comparison to 2.5% dextrose solution in patient treated with continuous ambulatory peritoneal dialysis (CAPD). Clinical Study Report RD-00-CA-022, January 24, 2002."},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib113","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA's statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"issue":"5","key":"10.1053\/j.ajkd.2019.10.004_bib114","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfr580","article-title":"Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis","volume":"27","author":"Han","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.ajkd.2009.05.014","article-title":"Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions","volume":"54","author":"Han","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/nep.12375","article-title":"Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients","volume":"20","author":"Wang","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib117","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.ajkd.2018.02.357","article-title":"In reply to 'the importance of icodextrin use for technique and patient survival in peritoneal dialysis.'","volume":"72","author":"See","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib118","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.ajkd.2017.10.019","article-title":"Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) study","volume":"72","author":"See","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2019.10.004_bib119","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.ajkd.2012.10.007","article-title":"Survival advantage of icodextrin peritoneal dialysis solution in a time-dependent model","volume":"61","author":"Ahn","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2019.10.004_bib120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s11255-016-1296-x","article-title":"Analysis of technique and patient survival over time in patients undergoing peritoneal dialysis","volume":"48","author":"Wang","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1053\/j.ajkd.2019.10.004_bib121","first-page":"108","article-title":"Icodextrin reduces mortality and the drop-out rate in Japanese peritoneal dialysis patients","volume":"22","author":"Kuriyama","year":"2006","journal-title":"Adv Perit Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2019.10.004_bib122","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3747\/pdi.2018.00217","article-title":"Icodextrin is associated with a lower mortality rate in peritoneal dialysis patients","volume":"39","author":"Yang","year":"2019","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.ajkd.2019.10.004_bib123","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1038\/sj.ki.5001920","article-title":"Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy","volume":"103","author":"Davies","year":"2006","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib124","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1097\/01.ASN.0000092146.67909.E2","article-title":"Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study","volume":"14","author":"Brown","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/089686080802800114","article-title":"High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis","volume":"28","author":"Yang","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.ajkd.2019.10.004_bib126","first-page":"81","article-title":"Cost savings from peritoneal dialysis therapy time extension using icodextrin","volume":"19","author":"Johnson","year":"2003","journal-title":"Adv Perit Dial"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib127","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5414\/CNP66263","article-title":"The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients","volume":"66","author":"Gursu","year":"2006","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.10.004_bib128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000371554","article-title":"The benefit of a glucose-sparing PD therapy on glycemic control measured by serum fructosamine in diabetic patients in a randomized, controlled trial (IMPENDIA)","volume":"129","author":"Li","year":"2015","journal-title":"Nephron"},{"issue":"11","key":"10.1053\/j.ajkd.2019.10.004_bib129","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2012100987","article-title":"Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients","volume":"24","author":"Li","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/089686080002000639","article-title":"Reduced 1,2-dicarbonyl compounds in bicarbonate\/lactate-buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids","volume":"20","author":"Schalkwijk","year":"2000","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.2003.00732.x","article-title":"Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid","volume":"63","author":"Ishikawa","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib132","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1046\/j.1523-1755.2000.00436.x","article-title":"Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids","volume":"58","author":"Ueda","year":"2000","journal-title":"Kidney Int"},{"issue":"40","key":"10.1053\/j.ajkd.2019.10.004_bib133","first-page":"2843","article-title":"Improved angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients with icodextrin (translated)","volume":"90","author":"Dai","year":"2010","journal-title":"Natl Med J China"},{"issue":"10","key":"10.1053\/j.ajkd.2019.10.004_bib134","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.02380218","article-title":"Biocompatible solutions and long-term changes in peritoneal solute transport","volume":"13","author":"Elphick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.10.004_bib135","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It's not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1053\/j.ajkd.2019.10.004_bib136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13643-018-0766-x","article-title":"The use of clinical\u00a0study reports to enhance the quality of systematic reviews: a survey of systematic review authors","volume":"7","author":"Hodkinson","year":"2018","journal-title":"Syst Rev"},{"issue":"9","key":"10.1053\/j.ajkd.2019.10.004_bib137","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005253","article-title":"Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus\u00a0full clinical study reports","volume":"4","author":"Jefferson","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"10.1053\/j.ajkd.2019.10.004_bib138","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.ajkd.2018.12.011","article-title":"Mortality in incident maintenance dialysis patients versus incident solid organ cancer patients: a population-based cohort","volume":"73","author":"Naylor","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"35","key":"10.1053\/j.ajkd.2019.10.004_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technol Assess"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619311151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619311151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:25:23Z","timestamp":1759461923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619311151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0272638619311151"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.004","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}